Sarcopenia, characterized by loss of skeletal muscle mass, quality, and strength, has
become a common hallmark of ageing and many chronic diseases. Diabetes mellitus …

Age associated increases in visceral adiposity and decreases in muscle mass (sarcopenia)
have been shown to contribute to disability in late life. Furthermore, there is evidence that …

The development of sarcopenia is a complex multi-factorial process which begins in mid-life
and accelerates after the age of 75 years. Although exercise, nutritional supplementation …

Sarcopenia is of important clinical relevance for loss of independence in older adults. The
prevalence of obesity in combination with sarcopenia ('sarcopenic-obesity') is increasing at …

Aging causes skeletal muscle atrophy, and myofiber loss can be a critical component of this
process. In 1989, Rosenberg emphasized the importance of the loss of skeletal muscle …

Sarcopenia, defined as a syndrome rather than as a pathology, is the loss of muscle mass
and function associated with age. Sarcopenia is an enigma for medicine, and despite the …

Background: Sarcopenia is defined as the loss of skeletal muscle mass and quality, which
accelerates with aging and is associated with functional decline. Rising obesity prevalence …

Sarcopenia is defined as an age-related loss of skeletal muscle mass and strength, and is a
major cause of disability and mobility limitations. Recent studies have demonstrated that …

Context The prevalence of sarcopenia in patients with diabetes is 3 times higher than that in
patients without diabetes and is associated with a poor prognosis. Objective To investigate …

One of the most dramatic age-related anatomic changes is that which occurs to skeletal
muscle mass. In 1989, Rosenberg 1 coined the term sarcopenia to refer to the age-related …